Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...

Shao Zhimin (right), director of general surgery and breast surgery departments of the Fudan University Shanghai Cancer Center and leader of the clinical study, is working on a patient case.